Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1828 (LINC01828) is a human long intergenic non-coding RNA (lincRNA), defined as an autonomously transcribed RNA longer than 200 nucleotides that does not overlap annotated protein coding genes. Like other lincRNAs, LINC01828 does not encode a protein but may be involved in the regulation of gene expression, modulation of chromatin structure, RNA stabilization, and transcriptional regulation. lincRNAs often show tissue specificity and can have enhancer-like activities, influencing expression of neighboring genes or participating in the formation of ribonucleoprotein complexes. There is currently no direct evidence of LINC01828 being a therapeutic target, nor specific disease associations or drug interactions reported for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1828 (LINC01828).